piggyBac system to co-express NKG2D CAR and IL-15 to augment the in vivo persistence and anti-AML activity of human peripheral blood NK cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

piggyBac system to co-express NKG2D CAR and IL-15 to augment the in vivo persistence and anti-AML activity of human peripheral blood NK cells

Published:2021-12 Issue: Volume:23 Page:582-596
ISSN:2329-0501
Container-title:Molecular Therapy - Methods & Clinical Development
language:en
Short-container-title:Molecular Therapy - Methods & Clinical Development

Author:

Du Zhicheng,Ng Yu Yang,Zha Shijun,Wang Shu

Funder

Ministry of Health -Singapore

Agency for Science, Technology and Research

National Medical Research Council

Publisher

Elsevier BV

Subject

Genetics,Molecular Biology,Molecular Medicine

Reference75 articles.

1. Recent advances in allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia;Bittencourt;Biol. Blood Marrow Transpl.,2020

2. Recent advances in allogeneic hematopoietic cell transplantation for acute myeloid leukemia;Gomez-Arteaga;Curr. Opin. Hematol.,2020

3. Clearance of acute myeloid leukemia by haploidentical natural killer cells is improved using IL-2 diphtheria toxin fusion protein;Bachanova;Blood,2014

4. Acute myeloid leukemia and NK cells: two warriors confront each other;Baragano Raneros;Oncoimmunology,2019

5. Complete remission with reduction of high-risk clones following haploidentical NK-cell therapy against MDS and AML;Bjorklund;Clin. Cancer Res.,2018

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CAR Macrophages: a promising novel immunotherapy for solid tumors and beyond;Biomarker Research;2024-08-23

2. Efficacy of NKG2D CAR-T cells with IL-15/IL-15Rα signaling for treating Epstein-Barr virus-associated lymphoproliferative disorder;Experimental Hematology & Oncology;2024-08-19

3. Targeting cytokine and chemokine signaling pathways for cancer therapy;Signal Transduction and Targeted Therapy;2024-07-22

4. CAR-T Cells in Acute Myeloid Leukemia: Where Do We Stand?;Biomedicines;2024-05-28

5. Beyond CAR T cells: exploring alternative cell sources for CAR-like cellular therapies;Biological Chemistry;2024-05-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3